Suscribirse

Cognitive Function in Dementia-Free Subjects and Survival in Old Age: The PROSPER Study - 12/12/19

Doi : 10.1016/j.amjmed.2019.06.001 
Somayeh Rostamian, MSc a, b, Sandra de Haan, MSc c, Jeroen van der Grond, PhD a, Mark A. van Buchem, MD, PhD a, Ian Ford, PhD d, J. Wouter Jukema, MD, PhD e, Behnam Sabayan, MD, PhD f,
a Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands 
b Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands 
c Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden 
d Robertson Centre for Biostatistics, University of Glasgow, United Kingdom 
e Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands 
f Northwestern University, Feinberg School of Medicine, Chicago, Ill 

Requests for reprints should be addressed to Behnam Sabayan, MD, PhD, Northwestern University, Feinberg School of Medicine, 303 E Chicago Ave, Chicago, IL 60611.Northwestern UniversityFeinberg School of Medicine303 E Chicago AveChicagoIL60611

Abstract

Background

Impairment in domain-specific cognitive function is associated with the increased risk of mortality. We prospectively evaluated the association of executive function and memory with the risk of long-term mortality in dementia-free older subjects. Moreover, we investigated the role of structural brain abnormalities in this association.

Methods

We included 547 dementia-free participants (mean age 78 years, 56.5% male) from the nested magnetic resonance imaging sub-study of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Cox proportional hazard models were used to model 10-year risk of all-cause, cardiovascular, and noncardiovascular mortality in relation to performance in executive function and memory. Moreover, we evaluated the role of total brain parenchymal volume, cerebral blood flow, white matter hyperintensity, and the presence of microbleeds and infarcts in the link between cognitive function and mortality.

Results

In the multivariable model, lower performance in executive function was associated with greater risk of all-cause (hazard ratio [HR] 1.49; 95% confidence interval [CI], 1.31-1.70), cardiovascular (HR 1.69; 95% CI, 1.36-2.11), and noncardiovascular (HR 1.36; 95% CI, 1.15-1.62) mortality. Similarly, poorer performance in memory tests associated with higher risk of all-cause (HR 1.47; 95% CI, 1.29-1.68), cardiovascular (HR 1.45; 95% CI, 1.15-1.83), and noncardiovascular (HR 1.49; 95% CI, 1.27-1.76) mortality. The associations were similar in subjects with various levels of brain structural abnormalities and cerebral blood flow (all P for interaction ≫ .05).

Conclusions

Poorer performance in both executive function and memory tests associates with all-cause, cardiovascular, and noncardiovascular mortality in elderly individuals. This association is independent of cardiovascular risk factors and diseases, brain structural abnormalities, and cerebral blood flow.

El texto completo de este artículo está disponible en PDF.

Keywords : Executive function, Memory, Mortality, Older subjects, Structural brain abnormalities


Esquema


 Funding: The original PROSPER clinical trial was founded by a grant from Bristol-Myers Squibb. The company had no involvement in the formulation of hypotheses, analysis of the data, or in any aspects of the preparation of this manuscript.
 Conflict of Interest: None.
 Authorship: All authors had access to the data and a role in writing this manuscript. SR, SH, and BS designed and conceptualized the study. SR and SH analyzed the data. SR drafted the manuscript for intellectual content. SR, SH, JG, MAB, IF, JWJ, and BS interpreted the data and critically revised the manuscript for intellectual content. All authors read and approved the final version of the manuscript and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Any data not published in this article are available at Leiden University Medical Centre. The datasets used and analyzed regarding the present study will be shared on request from any qualified investigator for reasonable purposes.


© 2019  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 132 - N° 12

P. 1466 - décembre 2019 Regresar al número
Artículo precedente Artículo precedente
  • Impact of Gait Speed on the Obesity Paradox in Older Patients With Cardiovascular Disease
  • Takeshi Nakamura, Kentaro Kamiya, Atsuhiko Matsunaga, Nobuaki Hamazaki, Ryota Matsuzawa, Kohei Nozaki, Masashi Yamashita, Emi Maekawa, Chiharu Noda, Minako Yamaoka-Tojo, Junya Ako
| Artículo siguiente Artículo siguiente
  • Words Matter: Removing the Word Pimp from Medical Education Discourse
  • Amulya Nagarur, John W. McEvoy, David A. Hirsh, Benjamin C. James

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.